Tina Susan Nova - 03 Mar 2022 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Reporting relationship: President, CLIA U.S.
Issuer ticker: VCYT
Reported as of: 03 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Mar 2022, 15:46:53 UTC
Prior SEC filing: 04 Mar 2022
Next SEC filing: 11 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Jane Alley, as Attorney-in-fact

Key filing fact

Tina Susan Nova filed Form 4 for VERACYTE, INC. (VCYT) on 07 Mar 2022.

Key facts

This page summarizes Tina Susan Nova's Form 4 filing for VERACYTE, INC. (VCYT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Mar 2022, 15:46.

Change

Previous filing in this sequence was filed on 04 Mar 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VCYT transaction

Common Stock

Award

Transaction value: $0
Shares: +56,546
Change %: +277%
Price: $0.000000
Shares after: 76,988
Date: 03 Mar 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VCYT transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +103,043
Change %
Price: $0.000000
Shares after: 103,043
Date: 03 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 103,043
Exercise price: $26.02
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted stock units awarded on March 3, 2022 vest 25% on March 2, 2023 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.

Footnote F2

The option becomes exercisable as to 25% of the shares on March 3, 2023, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.